West Pharmaceutical Services, Inc. a global leader in innovative solutions for injectable drug administration systems, announced FDA 510(k) clearance and launch of its Vial2Bag Advanced® 13mm admixture device.
The addition of the Vial2Bag Advanced® 13mm admixture device complements West's existing Vial2Bag Advanced® 20mm admixture device, with the two products providing options for the reconstitution and transfer of a drug using either a 13mm or 20mm vial and an IV bag before administration to the patient. The device is needle-free and has both a dual channel design to provide dedicated fluid pathways into and out of the IV bag and a robust vial spike design for connection to the drug vial.
"This year, West celebrates 100 years as an industry leader and scientific innovator in high-quality injectable solutions," said Cindy Reiss-Clark, Chief Commercial Officer at West. "The 13mm product is a key addition to our administration system portfolio, addressing the critical need for more drug preparation and delivery options at the point-of-care."
Vial2Bag Advanced® 13mm admixture device has been officially launched at Progressive Medical Inc's Booth #500 at the American Society of Health-System Pharmacists Midyear Clinical Meeting Dec. 3 through 7, in Anaheim, CA.
About Vial2Bag Advanced® 13mm Admixture Device and Important Product and Safety Information
The Vial2Bag Advanced® 13mm admixture device is indicated to serve as a connection between a 50, 100 or 250ml IV bag, vial with 13mm closure, and an external IV administration set. The integrated vial adapter makes it possible to reconstitute and/or admix drugs prior to administration to the patient. The Vial2Bag Advanced® 13mm admixture device is indicated for adolescent and adult patients only.
For more information, visit www.westpharma.com.
